Evidence map›Paper›PMID 41236254›Full record

ArticleDermatology practical & conceptual2025

Clinicopathological Factors Predicting Melanoma Recurrence: A Study From South East Ireland.

Aneela Razzaq, Maryam Shahad, Anam Allah Ditta

Abstract read
In one paragraph

Article in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aneela RazzaqDepartment of Breast, Endocrine and General Surgery, University Hospital Waterford, Ireland.
Maryam ShahadSurgical Registrar, Watim Medical and General Hospital, Pakistan.
Anam Allah DittaMilitary Hospital, Rawalpindi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCutaneous malignant melanoma is a neoplastic transformation of melanocytes and a major cause of skin cancer-related mortality. Ireland, with its fair-skinned population, continues to see rising incidence rates, highlighting the importance of identifying clinicopathological predictors of recurrence.

objectivesTo assess the relationship between excision margins and melanoma recurrence, with emphasis on anatomical distribution and clinicopathological features.

methodsThis retrospective observational study analyzed 565 patient records from University Hospital Waterford, Ireland, meeting predefined criteria. Data collected included age, sex, primary tumor site, disease stage, Breslow thickness, Clark level, mitotic figures, ulceration, lymphovascular invasion, sentinel lymph node involvement, and adequacy of excision margins. Statistical analysis was conducted using SPSS 26.0.

resultsSignificant predictors of recurrence included age ≥65 years, Breslow thickness >4.0 mm, Clark level IV-V, ulceration, lymphovascular invasion (P<0.001), and positive sentinel lymph node biopsy (P=0.004). Inadequate excision margins were also linked to increased recurrence. Conversely, early-stage disease, thin Breslow lesions (≤1.0 mm), and Clark level II were associated with lower recurrence risk.

conclusionsThis study demonstrates a significant association between narrow excision margins and melanoma recurrence, particularly in anatomically complex areas like the head and neck. The findings underscore the importance of individualized surgical planning to ensure oncological safety while preserving function and appearance. Adherence to excision margin guidelines and long-term follow-up are essential, especially in patients with high-risk histological features.

Identifiers

PMID41236254
PMCPMC12615110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.